Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer. | Investigators ADAURA, Wu Yi-Long, Tsuboi Masahiro, He Jie, John Thomas, Grohe Christian, Majem Margarita, Goldman Jonathan W, Laktionov Konstantin, Kim Sang-We, Kato Terufumi, Vu Huu-Vinh, Lu Shun, Lee Kye-Young, Akewanlop Charuwan, Yu Chong-Jen, de Marinis Filippo, Bonanno Laura, Domine Manuel, Shepherd Frances A, Zeng Lingmin, Hodge Rachel, Atasoy Ajlan, Rukazenkov Yuri, Herbst Roy S, Galetta Domenico | NEW ENGLAND JOURNAL OF MEDICINE | 74.699 |
Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations | Paik Paul K, Felip Enriqueta, Veillon Remi, Sakai Hiroshi, Cortot Alexis B, Garassino Marina C, Mazieres Julien, Viteri Santiago, Senellart Helene, Van Meerbeeck Jan, Raskin Jo, Reinmuth Niels, Conte Pierfranco, Kowalski Dariusz, Cho Byoung Chul, Patel Jyoti D, Horn Leora, Griesinger Frank, Han Ji-Youn, Kim Young-Chul, Chang Gee-Chen, Tsai Chen-Liang, Yang James C-H, Chen Yuh-Min, Smit Egbert F, van der Wekken Anthonie J, Kato Terufumi, Juraeva Dilafruz, Stroh Christopher, Bruns Rolf, Straub Josef, Johne Andreas, Scheele Jürgen, Heymach John V, Le Xiuning | NEW ENGLAND JOURNAL OF MEDICINE | 74.699 |
Cancer and COVID-19: what do we really know? | Poortmans Philip M., Guarneri Valentina, Cardoso Maria João | LANCET | 60.39 |
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study | Investigators TERAVOLT, Garassino Marina Chiara, Whisenant Jennifer G., Huang Li Ching, Trama Annalisa, Torri Valter, Agustoni Francesco, Baena Javier, Banna Giuseppe, Berardi Rossana, Bettini Anna Cecilia, Bria Emilio, Brighenti Matteo, Cadranel Jacques, De Toma Alessandro, Chini Claudio, Cortellini Alessio, Felip Enriqueta, Finocchiaro Giovanna, Garrido Pilar, Genova Carlo, Giusti Raffaele, Gregorc Vanesa, Grossi Francesco, Grosso Federica, Intagliata Salvatore, La Verde Nicla, Liu Stephen V., Mazieres Julien, Mercadante Edoardo, Michielin Olivier, Minuti Gabriele, Moro-Sibilot Denis, Pasello Giulia, Passaro Antonio, Scotti Vieri, Solli Piergiorgio, Stroppa Elisa, Tiseo Marcello, Viscardi Giuseppe, Voltolini Luca, Wu Yi Long, Zai Silvia, Pancaldi Vera, Dingemans Anne Marie, Van Meerbeeck Jan, Barlesi Fabrice, Wakelee Heather, Peters Solange, Horn Leora | LANCET ONCOLOGY | 33.752 |
Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study | Group European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life, Koller Michael, Shamieh Omar, Hjermstad Marianne J, Hornslien Kjersti, Young Teresa, Chalk Tara, Ioannidis Georgios, Harle Amelie, Johnson Colin D, Tomaszewski Krzysztof A, Serpentini Samantha, Pinto Monica, van der Weijst Lotte, Janssens Annelies, Morag Ofir, Chie Wei-Chu, Arraras Juan I, Pompili Cecilia, Jungraithmayr Wolfgang, Hechtner Marlene, Katsochi Despina, Müller Karolina, Gräfenstein Laura, Schulz Christian, Bottomley Andrew | LANCET ONCOLOGY | 33.752 |
Incidence of SARS-CoV-2 Infection Among Patients Undergoing Active Antitumor Treatment in Italy | Aschele Carlo, Negru Maria Emanuela, Pastorino Alessandro, Cavanna Luigi, zagonel vittorina, Barone-Adesi Francesco, Blasi Livio | JAMA Oncology | 24.799 |
Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: final overall survival results from SOLAR-1 | André F., Ciruelos E. M., Juric D., Loibl S., Campone M., Mayer I. A., Rubovszky G., Yamashita T., Kaufman B., Lu Y. S., Inoue K., Pápai Z., Takahashi M., Ghaznawi F., Mills D., Kaper M., Miller M., Conte Pierfranco, Iwata H., Rugo H. S. | ANNALS OF ONCOLOGY | 18.274 |
An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45 | EORTC Quality of Life Group and Breast Cancer Group Gruppo, Bjelic-Radisic V., Cardoso F., Cameron D., Brain E., Kuljanic K., da Costa R. A., Conroy T., Inwald E. C., Serpentini Samantha, Pinto M., Weis J., Morag O., Lindviksmoen Astrup G., Tomaszweksi K. A., Pogoda K., Sinai P., Sprangers M., Aaronson N., Velikova G., Greimel E., Arraras J., Bottomley A., Bleiker Eveline, Bliem Brigitte, Chie Weichu, Creutzberg Carien, Deville Valerie, Duhoux Francois, Eilf Kirsten, Hartup Sue, Koller Michael, Nagele Eva, Nicolatou-Galitis Ourania, Oberguggenberger Anne, Schmalz Claudia, Winters Zoe | ANNALS OF ONCOLOGY | 18.274 |
Time course and management of key adverse events during the randomized phase III SOLAR-1 study of PI3K inhibitor alpelisib plus fulvestrant in patients with HR-positive advanced breast cancer | Rugo H S, André F, Yamashita T, Cerda H, Toledano I, Stemmer S M, Jurado J C, Juric D, Mayer I, Ciruelos E M, Iwata H, Conte Pierfranco, Campone M, Wilke C, Mills D, Lteif A, Miller M, Gaudenzi F, Loibl S | ANNALS OF ONCOLOGY | 18.274 |
A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial | Peters Solange, Danson Sarah, Hasan Baktiar, Dafni Urania, Reinmuth Niels, Majem Margarita, Tournoy Kurt G, Mark Michael T, Pless Miklos, Cobo Manuel, Rodriguez-Abreu Delvys, Falchero Lionel, Moran Teresa, Ortega Granados Ana Laura, Monnet Isabelle, Mohorcic Katja, Sureda Bartomeu Massutí, Betticher Daniel, Demedts Ingel, Macias Jose Antionio, Cuffe Sinead, Luciani Andrea, Sanchez Jose Garcia, Curioni-Fontecedro Alessandra, Gautschi Oliver, Price Gillian, Coate Linda, von Moos Roger, Zielinski Christoph, Provencio Mariano, Menis Jessica, Ruepp Barbara, Pochesci Alessia, Roschitzki-Voser Heidi, Besse Benjamin, Rabaglio Manuela, O’Brien Mary E R, Stahel Rolf A | JOURNAL OF THORACIC ONCOLOGY | 13.357 |
Checkpoint Inhibitors in SCLC: How Much Can We Trust in Randomized Cohorts of Phase I/II Trials? | Menis Jessica, Reck Martin | JOURNAL OF THORACIC ONCOLOGY | 13.357 |
Combination of Immunotherapy and Radiotherapy- The Next Magic Step in the Management of Lung Cancer? | Hendriks Lizza E.L., Menis Jessica, De Ruysscher Dirk K.M., Reck Martin | JOURNAL OF THORACIC ONCOLOGY | 13.357 |
Overall Survival of CDK4/6-Inhibitor-Based Treatments in Clinically Relevant Subgroups of Metastatic Breast Cancer: Systematic Review and Meta-Analysis | Schettini Francesco, Giudici Fabiola, Giuliano Mario, Cristofanilli Massimo, Arpino Grazia, Del Mastro Lucia, Puglisi Fabio, De Placido Sabino, Paris Ida, De Placido Pietro, Venturini Sergio, De Laurentis Michelino, Conte Pierfranco, Juric Dejan, Llombart-Cussac Antonio, Pusztai Lajos, Prat Aleix, Jerusalem Guy, Di Leo Angelo, Generali Daniele | JOURNAL OF THE NATIONAL CANCER INSTITUTE | 11.577 |
Real world data in the era of Immune Checkpoint Inhibitors (ICIs): Increasing evidence and future applications in lung cancer | Pasello Giulia, Pavan Alberto, Attili Ilaria, Bortolami Alberto, Bonanno Laura, Menis Jessica, Conte Pierfranco, Guarneri Valentina | CANCER TREATMENT REVIEWS | 8.885 |
Repeat Screening Outcomes with Digital Breast Tomosynthesis Plus Synthetic Mammography for Breast Cancer Detection: Results from the Prospective Verona Pilot Study | Caumo Francesca, Montemezzi Stefania, Romanucci Giovanna, Brunelli Silvia, Bricolo Paola, Cugola Loredana, Gennaro Gisella Maria | RADIOLOGY | 7.931 |